Smith & Nephew Snats (SNN) 32.76 $SNN
Smith & Nephew: Post-Operative Use of PICO(TM) Single Use Negative Pressure Wound Therapy Improves Predictability in Wound Healing and Reduces Complications Following Orthopaedic Surgery.
BusinessWire - Thu Sep 08, 2:00AM CDT
Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the publication of new clinical evidence highlighting improved patient outcomes following orthopaedic surgery.(1)
SNN: 32.76 (+0.03)
Smith & Nephew: Evidence and Expert Opinion Highlights Clinical and Aesthetic Benefits of PICOa-S Single-Use Negative Pressure Wound Therapy in Mammoplasty and Oncological Breast Reconstructive Surgery
BusinessWire - Tue Aug 30, 3:00AM CDT
Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces how expert opinion around the world continues to build around the use of PICO, a novel single use negative pressure wound therapy (NPWT) in avoiding post-operative wound complications. At a recent meeting hosted by Smith & Nephew in Paris, over 160 European experts in plastic and onco-plastic surgery met to share the latest evidenced based best practice around the use of PICO, in the prevention of incisional complications following breast surgery.
SNN: 32.76 (+0.03)
ACell®, Inc. Names Brad Adams Vice President of Sales
PR Newswire - Mon Aug 22, 5:55AM CDT
ACell, Inc. today announced that it has named Brad Adams Vice President of Sales. He will be responsible for directing the strategy and execution of both field sales and national accounts.
SNN: 32.76 (+0.03)
Trauma Fixation Companies Analysis & Forecast 2016-2021 for Smith & Nephew, Zimmer, Stryker & DePuy Synthes - Research and Markets
BusinessWire - Mon Aug 22, 4:52AM CDT
Research and Markets has announced the addition of the "Trauma Fixation Companies (Smith & Nephew, Zimmer, Stryker & DePuy Synthes) Analysis & Forecast" report to their offering.
SNN: 32.76 (+0.03)
Downgrade Alert for Smith & Nephew (SNN)
Comtex SmarTrend(R) - Thu Aug 11, 3:44AM CDT
Smith & Nephew (NYSE:SNN) was downgraded from Overweight to Equal Weight at Barclays Capital today. The stock closed yesterday at $33.28 on volume of 338,000 shares, above average daily volume of 302,000. Smith & Nephew plc develops and markets advanced medical devices. The Group is involved in orthopaedics, endoscopy, and advanced wound management.
SNN: 32.76 (+0.03)
Global Osteosynthesis Devices Market 2016-2020 with DePuy Synthes, Smith & Nephew, Stryker & Zimmer Biomet Dominating - Research and Markets
BusinessWire - Tue Aug 09, 9:50AM CDT
Research and Markets has announced the addition of the "Global Osteosynthesis Devices Market 2016-2020" report to their offering.
SNN: 32.76 (+0.03)
Smith & Nephew's NAVIO(TM) Surgical System achieves robotics-assisted milestone for total knee replacement surgery
PR Newswire - Thu Jul 28, 7:00AM CDT
Smith & Nephew (NYSE:SNN; LSE:SN), the global medical technology business, today announces the first surgical case of its robotics-assisted total knee replacement procedure. The new approach, which recently received 510(k) clearance from the US Food and Drug Administration, uses the NAVIO Surgical System to implant the JOURNEY(TM) II BCS and CR total knee systems.
SNN: 32.76 (+0.03)
After Yesterday's Rally of 1.15% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Jun 22, 3:49PM CDT
Smith & Nephew (NYSE:SNN) traded in a range yesterday that spanned from a low of $34.19 to a high of $34.64. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $34.26 on volume of 228,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SNN: 32.76 (+0.03)
Australian Hyaluronic Acid Viscosupplementation Market Report 2016 Featuring Genzyme (Sanofi) & Bioventus (Smith & Nephew) - Research and Markets
BusinessWire - Mon Jun 20, 8:11AM CDT
Research and Markets has announced the addition of the "Australian Market Report for Hyaluronic Acid Viscosupplementation" report to their offering.
SNN: 32.76 (+0.03)
Global Sports Medicine Market 2016-2020 - Key Vendors are Arthrex, CONMED, DePuy Synthes, Smith & Nephew & Stryker
GlobeNewswire - Wed Jun 15, 8:19AM CDT
Research and Markets has announced the addition of the "Global Sports Medicine Market 2016-2020" report to their offering.
SNN: 32.76 (+0.03), CNMD: 39.71 (+0.71)
International companies to host live webcasts at Deutsche Bank's June 9th and 10th Depositary Receipts Virtual Investor Conference
PR Newswire Europe - Mon Jun 06, 8:01AM CDT
Deutsche Bank today announced the lineup for its June 9(th) and 10(th) Depositary Receipts Virtual Investor Conference ("dbVIC"
, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US.
SNN: 32.76 (+0.03), DL: 12.50 (+0.12), HCM: 12.29 (-0.18), DB: 12.97 (-0.41)
Orthopedic Surgeons from Around the World Travel to Colorado for the Vail International Knee Symposium (VICKS) June 9-11
PRWeb - Wed Jun 01, 7:07AM CDT
Robert LaPrade MD, PhD and Lars Engebretsen MD, PhD are teaming up with Smith & Nephew to host the 3rd Annual Vail International Knee Symposium (VICKS) in Vail, Colorado June 9 - 11, 2016. Throughout the course, attendees will gain hands-on experience with cadaveric training and hear case discussions from leading international experts on the latest techniques and technologies in knee arthroscopy.
SNN: 32.76 (+0.03)
Intelex Client Smith & Nephew Wins 2016 EH&S Information Management Award
PRWeb - Tue May 31, 9:12AM CDT
Smith & Nephew, a global medical technology business, was a recipient of the inaugural EH&S Information Management Award given out at the 2016 Verdantix Summit. One of only eight winners announced, Smith & Nephew won in the healthcare category for their development of an integrated safety and incident management system. Through its successful project for Smith & Nephew's Memphis location, Intelex Technologies, a global innovator of cloud-based environmental, health, safety, and quality (EHSQ) management software received a Verdantix EH&S Innovation Award.
SNN: 32.76 (+0.03)
Hip and Knee Orthopedic Surgical Implants - Global Market Outlook (2015-2022)
PR Newswire - Tue May 24, 4:32PM CDT
According to Stratistics MRC, the Global Hip and Knee Orthopedic Surgical Implants market is estimated at $18.26 billion in 2015 and is expected to grow at a CAGR of 9.54% to reach $34.57 billion by 2022. Technological advancements and rising geriatric population worldwide are some of the key factors fueling the market growth. On the other hand, abridged reimbursements by insurance companies are negatively affecting the market growth. Total hip replacement surgery is witnessing a significant rise driven by the technological advan. The aging US population is supporting the market demand, since the requirement of these medical devices is higher in the elderly population.
SNN: 32.76 (+0.03), JNJ: 117.66 (-0.59)
Medtronic to Expand Minimally Invasive Therapy Portfolio with Acquisition of Gynecology Business from Smith & Nephew
Globe Newswire - Wed May 18, 7:01AM CDT
DUBLIN - May 18, 2016 - Medtronic plc (NYSE: MDT) today announced it has signed a definitive agreement to acquire Smith & Nephew's (NYSE: SNN; LSE: SN) gynecology (GYN) business for approximately $350 million. This agreement reinforces Medtronic's dedication to expanding the use of less invasive treatments and demonstrates a commitment to improving options for women with abnormal uterine bleeding (AUB). The addition of the GYN portfolio will expand and strengthen Medtronic's minimally invasive surgical offerings and will further complement its existing global GYN business. The acquisition is expected to close this summer.
SNN: 32.76 (+0.03), MDT: 85.99 (-0.02)
Global Orthopaedic Device Company Profiles of The Top 5 - DePuy Synthes, Medtronic, Smith & Nephew, Stryker & Zimmer Biomet - Research and Markets
BusinessWire - Wed May 18, 6:50AM CDT
Research and Markets has announced the addition of the "Orthopaedic Device Company Profiles: The Top 5" company profile to their offering.
SNN: 32.76 (+0.03), MDT: 85.99 (-0.02)
Upgrade Alert for Smith & Nephew (SNN)
Comtex SmarTrend(R) - Tue May 10, 4:09AM CDT
Smith & Nephew (NYSE:SNN) was upgraded from Hold to Buy at Jefferies today. The stock closed yesterday at $34.04 on volume of 371,000 shares, above average daily volume of 302,000. There is potential upside of 17.1% for shares of Smith & Nephew based on a current price of $34.04 and an average consensus analyst price target of $39.88. The stock should hit resistance at its 200-day moving average (MA) of $34.17, as well as support at its 50-day MA of $33.33.
SNN: 32.76 (+0.03)
Laparoscopic Devices Market: Global Industry Analysis 2015-2025 - Key Players are Medtronic, Ethicon US LLC & Smith & Nephew - Research and Markets
BusinessWire - Mon Apr 18, 7:52AM CDT
Research and Markets has announced the addition of the "Laparoscopic Devices Market: Global Industry Analysis and Opportunity Assessment 2015-2025" report to their offering.
SNN: 32.76 (+0.03)
Smith & Nephew: Post-Operative Use of PICO(TM) Single Use Negative Pressure Wound Therapy Improves Predictability in Wound Healing and Reduces Complications Following Orthopaedic Surgery.
BusinessWire - Thu Sep 08, 2:00AM CDT
Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the publication of new clinical evidence highlighting improved patient outcomes following orthopaedic surgery.(1)
SNN: 32.76 (+0.03)
Smith & Nephew: Evidence and Expert Opinion Highlights Clinical and Aesthetic Benefits of PICOa-S Single-Use Negative Pressure Wound Therapy in Mammoplasty and Oncological Breast Reconstructive Surgery
BusinessWire - Tue Aug 30, 3:00AM CDT
Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces how expert opinion around the world continues to build around the use of PICO, a novel single use negative pressure wound therapy (NPWT) in avoiding post-operative wound complications. At a recent meeting hosted by Smith & Nephew in Paris, over 160 European experts in plastic and onco-plastic surgery met to share the latest evidenced based best practice around the use of PICO, in the prevention of incisional complications following breast surgery.
SNN: 32.76 (+0.03)
ACell®, Inc. Names Brad Adams Vice President of Sales
PR Newswire - Mon Aug 22, 5:55AM CDT
ACell, Inc. today announced that it has named Brad Adams Vice President of Sales. He will be responsible for directing the strategy and execution of both field sales and national accounts.
SNN: 32.76 (+0.03)
Trauma Fixation Companies Analysis & Forecast 2016-2021 for Smith & Nephew, Zimmer, Stryker & DePuy Synthes - Research and Markets
BusinessWire - Mon Aug 22, 4:52AM CDT
Research and Markets has announced the addition of the "Trauma Fixation Companies (Smith & Nephew, Zimmer, Stryker & DePuy Synthes) Analysis & Forecast" report to their offering.
SNN: 32.76 (+0.03)
Downgrade Alert for Smith & Nephew (SNN)
Comtex SmarTrend(R) - Thu Aug 11, 3:44AM CDT
Smith & Nephew (NYSE:SNN) was downgraded from Overweight to Equal Weight at Barclays Capital today. The stock closed yesterday at $33.28 on volume of 338,000 shares, above average daily volume of 302,000. Smith & Nephew plc develops and markets advanced medical devices. The Group is involved in orthopaedics, endoscopy, and advanced wound management.
SNN: 32.76 (+0.03)
Global Osteosynthesis Devices Market 2016-2020 with DePuy Synthes, Smith & Nephew, Stryker & Zimmer Biomet Dominating - Research and Markets
BusinessWire - Tue Aug 09, 9:50AM CDT
Research and Markets has announced the addition of the "Global Osteosynthesis Devices Market 2016-2020" report to their offering.
SNN: 32.76 (+0.03)
Smith & Nephew's NAVIO(TM) Surgical System achieves robotics-assisted milestone for total knee replacement surgery
PR Newswire - Thu Jul 28, 7:00AM CDT
Smith & Nephew (NYSE:SNN; LSE:SN), the global medical technology business, today announces the first surgical case of its robotics-assisted total knee replacement procedure. The new approach, which recently received 510(k) clearance from the US Food and Drug Administration, uses the NAVIO Surgical System to implant the JOURNEY(TM) II BCS and CR total knee systems.
SNN: 32.76 (+0.03)
After Yesterday's Rally of 1.15% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Jun 22, 3:49PM CDT
Smith & Nephew (NYSE:SNN) traded in a range yesterday that spanned from a low of $34.19 to a high of $34.64. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $34.26 on volume of 228,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SNN: 32.76 (+0.03)
Australian Hyaluronic Acid Viscosupplementation Market Report 2016 Featuring Genzyme (Sanofi) & Bioventus (Smith & Nephew) - Research and Markets
BusinessWire - Mon Jun 20, 8:11AM CDT
Research and Markets has announced the addition of the "Australian Market Report for Hyaluronic Acid Viscosupplementation" report to their offering.
SNN: 32.76 (+0.03)
Global Sports Medicine Market 2016-2020 - Key Vendors are Arthrex, CONMED, DePuy Synthes, Smith & Nephew & Stryker
GlobeNewswire - Wed Jun 15, 8:19AM CDT
Research and Markets has announced the addition of the "Global Sports Medicine Market 2016-2020" report to their offering.
SNN: 32.76 (+0.03), CNMD: 39.71 (+0.71)
International companies to host live webcasts at Deutsche Bank's June 9th and 10th Depositary Receipts Virtual Investor Conference
PR Newswire Europe - Mon Jun 06, 8:01AM CDT
Deutsche Bank today announced the lineup for its June 9(th) and 10(th) Depositary Receipts Virtual Investor Conference ("dbVIC"
, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US. SNN: 32.76 (+0.03), DL: 12.50 (+0.12), HCM: 12.29 (-0.18), DB: 12.97 (-0.41)
Orthopedic Surgeons from Around the World Travel to Colorado for the Vail International Knee Symposium (VICKS) June 9-11
PRWeb - Wed Jun 01, 7:07AM CDT
Robert LaPrade MD, PhD and Lars Engebretsen MD, PhD are teaming up with Smith & Nephew to host the 3rd Annual Vail International Knee Symposium (VICKS) in Vail, Colorado June 9 - 11, 2016. Throughout the course, attendees will gain hands-on experience with cadaveric training and hear case discussions from leading international experts on the latest techniques and technologies in knee arthroscopy.
SNN: 32.76 (+0.03)
Intelex Client Smith & Nephew Wins 2016 EH&S Information Management Award
PRWeb - Tue May 31, 9:12AM CDT
Smith & Nephew, a global medical technology business, was a recipient of the inaugural EH&S Information Management Award given out at the 2016 Verdantix Summit. One of only eight winners announced, Smith & Nephew won in the healthcare category for their development of an integrated safety and incident management system. Through its successful project for Smith & Nephew's Memphis location, Intelex Technologies, a global innovator of cloud-based environmental, health, safety, and quality (EHSQ) management software received a Verdantix EH&S Innovation Award.
SNN: 32.76 (+0.03)
Hip and Knee Orthopedic Surgical Implants - Global Market Outlook (2015-2022)
PR Newswire - Tue May 24, 4:32PM CDT
According to Stratistics MRC, the Global Hip and Knee Orthopedic Surgical Implants market is estimated at $18.26 billion in 2015 and is expected to grow at a CAGR of 9.54% to reach $34.57 billion by 2022. Technological advancements and rising geriatric population worldwide are some of the key factors fueling the market growth. On the other hand, abridged reimbursements by insurance companies are negatively affecting the market growth. Total hip replacement surgery is witnessing a significant rise driven by the technological advan. The aging US population is supporting the market demand, since the requirement of these medical devices is higher in the elderly population.
SNN: 32.76 (+0.03), JNJ: 117.66 (-0.59)
Medtronic to Expand Minimally Invasive Therapy Portfolio with Acquisition of Gynecology Business from Smith & Nephew
Globe Newswire - Wed May 18, 7:01AM CDT
DUBLIN - May 18, 2016 - Medtronic plc (NYSE: MDT) today announced it has signed a definitive agreement to acquire Smith & Nephew's (NYSE: SNN; LSE: SN) gynecology (GYN) business for approximately $350 million. This agreement reinforces Medtronic's dedication to expanding the use of less invasive treatments and demonstrates a commitment to improving options for women with abnormal uterine bleeding (AUB). The addition of the GYN portfolio will expand and strengthen Medtronic's minimally invasive surgical offerings and will further complement its existing global GYN business. The acquisition is expected to close this summer.
SNN: 32.76 (+0.03), MDT: 85.99 (-0.02)
Global Orthopaedic Device Company Profiles of The Top 5 - DePuy Synthes, Medtronic, Smith & Nephew, Stryker & Zimmer Biomet - Research and Markets
BusinessWire - Wed May 18, 6:50AM CDT
Research and Markets has announced the addition of the "Orthopaedic Device Company Profiles: The Top 5" company profile to their offering.
SNN: 32.76 (+0.03), MDT: 85.99 (-0.02)
Upgrade Alert for Smith & Nephew (SNN)
Comtex SmarTrend(R) - Tue May 10, 4:09AM CDT
Smith & Nephew (NYSE:SNN) was upgraded from Hold to Buy at Jefferies today. The stock closed yesterday at $34.04 on volume of 371,000 shares, above average daily volume of 302,000. There is potential upside of 17.1% for shares of Smith & Nephew based on a current price of $34.04 and an average consensus analyst price target of $39.88. The stock should hit resistance at its 200-day moving average (MA) of $34.17, as well as support at its 50-day MA of $33.33.
SNN: 32.76 (+0.03)
Laparoscopic Devices Market: Global Industry Analysis 2015-2025 - Key Players are Medtronic, Ethicon US LLC & Smith & Nephew - Research and Markets
BusinessWire - Mon Apr 18, 7:52AM CDT
Research and Markets has announced the addition of the "Laparoscopic Devices Market: Global Industry Analysis and Opportunity Assessment 2015-2025" report to their offering.
SNN: 32.76 (+0.03)
